Place of therapeutic cannabis in France and safety data: A literature review.

Author: BacleA, CorsoB, DemayE, GicquelT, Le DaréB, MercerolleM, PelletierR

Paper Details 
Original Abstract of the Article :
To date, very few cannabis-based specialities are authorised on the French market despite a growing demand from patients and health professionals. The objective of this study is to review the tolerance profile and the French legislative status of the two main cannabinoids used for therapeutic purpos...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.pharma.2023.02.002

データ提供:米国国立医学図書館(NLM)

Therapeutic Cannabis in France: Exploring Safety and Legality

This study examines the growing demand for cannabis-based therapies in France and explores the safety data and legislative landscape surrounding these treatments. The study focuses on two key cannabinoids: tetrahydrocannabinol (THC), which has psychoactive effects, and cannabidiol (CBD), which is non-psychoactive. The objective is to review the tolerance profile of these cannabinoids and their current legal status in France.

Navigating the Complexities of Therapeutic Cannabis

This study acknowledges the increasing interest in therapeutic cannabis in France. However, it also highlights the challenges associated with navigating the legal and regulatory complexities of these treatments. The research emphasizes the need for robust safety data and a clear understanding of the tolerance profile of THC and CBD to ensure responsible and effective use of these substances for therapeutic purposes.

Balancing Therapeutic Benefits and Safety Concerns

The study underscores the importance of balancing the potential therapeutic benefits of cannabis-based treatments with the need for safety considerations. It highlights the need for further research to establish the optimal therapeutic doses and long-term safety of these substances. This research emphasizes the critical role of ongoing scientific investigation and regulatory oversight in ensuring the safe and effective use of therapeutic cannabis.

Dr. Camel's Conclusion

Imagine a vast desert with a hidden oasis, holding potential medicinal treasures. This study is like a guide, helping us understand the complexities of this oasis—therapeutic cannabis—and how to approach it safely and wisely. The study urges caution and continued research to fully understand the benefits and risks of using cannabis for therapeutic purposes. This research reminds us that a journey into the unknown, like navigating the desert, requires careful planning and a constant awareness of the landscape.
Date :
  1. Date Completed 2023-06-05
  2. Date Revised 2023-06-05
Further Info :

Pubmed ID

36841395

DOI: Digital Object Identifier

10.1016/j.pharma.2023.02.002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.